payor coverage ACMG Urges Expanded Telegenetics Services to Address Growing Demand, Reduce Health Disparities In a new policy statement, ACMG wants the US to make permanent the relaxed telehealth rules adopted during the COVID-19 pandemic. Adaptive Biotech's ClonoSeq Gets Expanded Medicare Coverage For B-Cell Lymphoma The firm's assay is the first and only test to gain coverage for this patient population, for whom ctDNA MRD assessment can help personalize treatment. California, Other States to Cover Rapid WGS of Newborns Under Medicaid, but Questions of Access Loom Premium Though the funding is technically there, doctors may not be comfortable ordering the test and hospitals may wonder if they'll lose money from it. Intermountain Healthcare Rolling Out Galleri Multi-Cancer Early Detection Test in Pilot Program Premium The test is first available to employees over age 50 covered under Intermountain's SelectHealth, but the health system has a bigger five-year plan. Biocept HER2 Assay Gains Coverage Under Medicare Local Coverage Determination for CTC Tests Under the LCD, CTC assays, such as Biocept's, will now be covered to guide targeted treatment decisions for patients with breast and other cancers under certain circumstances. Jul 6, 2021 Concert Genetics New Test ID Tool Works to Improve Reimbursement Process Premium Mar 16, 2021 New AMP Survey Reports Insufficient Reimbursement for Analysis, Interpretation of MDx Test Results Mar 1, 2021 Bio-Techne Obtains Reimbursement Contract With Humana for Exosome Diagnostics Prostate Biopsy Test Feb 23, 2021 German Medical Center to Report Polygenic Risk Scores as Part of Clinical Whole-Genome Testing Premium Jan 26, 2021 Genomind Receives Medicare Coverage for Pharmacogenetics Test Jan 20, 2021 CMS Finalizes Blood-Based Colon Cancer Screening NCD with Non-Coverage for Epi ProColon Dec 8, 2020 Illumina, Harvard Pilgrim Health Care Ink Risk-Sharing Deal for Whole-Genome Sequencing Dec 3, 2020 Aetna Updates Noninvasive Prenatal Testing Coverage Policy to Include All Pregnancies Dec 1, 2020 UnitedHealthcare to Cover NIPT for Average-Risk Pregnancies Nov 20, 2020 Increased Adoption of Whole-Genome Sequencing Testing Hinges on Acceptance by Payors, Providers Premium Nov 19, 2020 Progenity to Cut Workforce as Third-Party Payor Seeks $27.4M for Alleged Overpayment Oct 29, 2020 Humana Broadens Coverage of NIPT for Average Risk Pregnancies Oct 19, 2020 CMS Colon Cancer Screening Memo Bodes Well for Assays in Development; Denies Epi ProColon Oct 15, 2020 Germany Grants National Reimbursement for Three Additional Breast Cancer Biomarker Tests Oct 8, 2020 Centene Expands Coverage of Natera NIPT to All Pregnant Women Sep 21, 2020 Biocept Lung Cancer Liquid Biopsy Test Obtains Coverage From Blue Cross Affiliate Highmark Aug 6, 2020 NantHealth Q2 Revenues Decline 12 Percent Jul 8, 2020 Payor Policy Study Reveals Progress, Challenges in Liquid Biopsy Reimbursement Jun 18, 2020 State-Funded Rapid WGS Pilot Improves Outcomes, Saves Costs in Critically Ill California Newborns Premium May 20, 2020 Bio-Techne Bets Clinical Utility Study Data Will Sway Payors to Cover Prostate Cancer Risk Test Premium Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.